Neonate with chronic meningitis and hydrocephalus

Pediatric Infectious Disease Journal

Volumn 22, Issue 11, 2003, Pages 1025-1026+1030

  Singh, Jasjit ^a   Arrieta, Antonio ^a   Lang, David J ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Hydrocephalus; Meningitis; Neonate; Ureaplasma infection

Indexed keywords

ACICLOVIR; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; DEXAMETHASONE; DOXYCYCLINE; FLUCONAZOLE; MEROPENEM; PHENOBARBITAL; PROPRANOLOL; TROVAFLOXACIN; VANCOMYCIN;

ARTICLE; ASEPTIC MENINGITIS; BIRTH WEIGHT; BLOOD CULTURE; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CHORIOAMNIONITIS; CLINICAL FEATURE; DELIVERY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HOSPITALIZATION; HUMAN; HYDROCEPHALUS; LEUKOCYTE COUNT; NEUROLOGIC EXAMINATION; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEIZURE; URINE CULTURE;

CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDROCEPHALUS; INFANT, NEWBORN; MENINGITIS; MYCOPLASMA; MYCOPLASMA INFECTIONS;

EID: 0344413609     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000097100.29478.30     Document Type: Article

References (11)

1. Waites KB, Crouse DT, Cassell GH. Systemic neonatal infection due to Ureaplasma urealyticum. Clin Infect Dis 1993; 17(Suppl):S131-5.
2. Shaw NJ, Pratt BC, Weindling AM. Ureaplasma, Mycoplasma infections of the central nervous system in preterm infants. Lancet 1989;2:1530-1.
3. Waites KB, Crouse Dt, Nelson KG, et al. Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants. Lancet 1988;1:17-21.
4. Waites KB, Duffy LB, Crouse DT, et al. Mycoplasma infections of cerebrospinal fluid in newborn infants from a community hospital population. Pediatr Infect Dis J 1990;9: 241-5.
5. Stahelin-Massik J, Levy F, Friderich P, et al. Meningitis caused by Ureaplasma urealyticum in a full term neonate. Pediatr Infect Dis J 1994;13:419-20.
6. Cassell GH, Waites KB, Crouse DT. Perinatal Mycoplasma infections. Clin Perinatol 1991;18:241-62.
7. Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis, M. pneumoniae and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, maxifloxacin, quinupristen-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines and quinolones. Antimicrob Agents Chemother 2001;45:2608.
8. Waites KB, Crouse DT, Cassell GH. Therapeutic considerations for Ureaplasma urealyticum infections in neonates. Clin Infect Dis 1993;17(Suppl 1):S208-14.
9. Duffy LB, Crabb D, Searcy K, et al. Comparative potency of gemifioxacin, new quinolones, macrolides, tetracycline, and clindamycin against Mycoplasma spp. J Antimicrob Chemother 2000;45(Suppl S1):29-33.
10. Bebear CM, Renaudin H, Charron A, et al. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Urea-plasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob Agents Chemother 2000;44:2557-60. Pediatr Infect Dis J 1990;9:241-5.
11. Bebear CM, Renaudin H, Charron A, et al. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Urea-plasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. Antimicrob Agents Chemother 2000;44:2557-60. Pediatr Infect Dis J 1990;9:241-5.